David Howard | Authors

Articles

What’s Next With Next-Generation BRAF Inhibitors?

April 15, 2014

Targeted therapy for patients with activating BRAF mutations has demonstrated the potential for personalized medicine in patients with metastatic melanoma. Initial study results were promising and dramatic.